Page last updated: 2024-08-16

propofol and 1-hexadecyl-2-acetyl-glycero-3-phosphocholine

propofol has been researched along with 1-hexadecyl-2-acetyl-glycero-3-phosphocholine in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chap, H; Fourcade, O; Litt, L; Samii, K; Simon, MF	1

Other Studies

1 other study(ies) available for propofol and 1-hexadecyl-2-acetyl-glycero-3-phosphocholine

Article	Year
Propofol inhibits human platelet aggregation induced by proinflammatory lipid mediators. Anesthesia and analgesia, 2004, Volume: 99, Issue:2 Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Anesthetics, Intravenous; Blood Platelets; Calcium; Dose-Response Relationship, Drug; Humans; In Vitro Techniques; Inflammation Mediators; Lysophospholipids; Platelet Activating Factor; Platelet Aggregation; Propofol; Receptors, Cell Surface; Thromboxane A2	2004

Article

Year

Propofol inhibits human platelet aggregation induced by proinflammatory lipid mediators.

Anesthesia and analgesia, 2004, Volume: 99, Issue:2

Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Anesthetics, Intravenous; Blood Platelets; Calcium; Dose-Response Relationship, Drug; Humans; In Vitro Techniques; Inflammation Mediators; Lysophospholipids; Platelet Activating Factor; Platelet Aggregation; Propofol; Receptors, Cell Surface; Thromboxane A2

2004